@article{11081,
  keywords = {Adult, Humans, Female, Middle Aged, Male, *Diabetes Mellitus, Type 2/complications/drug therapy/epidemiology, *Metformin/adverse effects, Cohort Studies, Hypoglycemic Agents/adverse effects, Glucose, *Dementia/epidemiology/prevention & control, Primary health care, United Kingdom/epidemiology, dementia, diabetes mellitus, type 2, Electronic Health Records, metformin},
  author = {W. Doran and L. Tunnicliffe and R. Muzambi and C. Rentsch and K. Bhaskaran and L. Smeeth and C. Brayne and D. Williams and N. Chaturvedi and S. Eastwood and S. Dunachie and R. Mathur and C. Warren-Gash},
  title = {Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records},
  year = {2024},
  journal = {BMJ Open Diabetes Res Care},
  volume = {12},
  edition = {2024/01/26},
  number = {1},
  isbn = {2052-4897},
  doi = {10.1136/bmjdrc-2023-003548},
  note = {2052-4897
Doran, William
Tunnicliffe, Louis
Muzambi, Rutendo
Rentsch, Christopher T
Orcid: 0000-0002-1408-7907
Bhaskaran, Krishnan
Smeeth, Liam
Brayne, Carol
Williams, Dylan M
Chaturvedi, Nish
Eastwood, Sophie V
Dunachie, Susanna J
Mathur, Rohini
Warren-Gash, Charlotte
Orcid: 0000-0003-4524-3180
WT_/Wellcome Trust/United Kingdom
Journal Article
Observational Study
England
BMJ Open Diabetes Res Care. 2024 Jan 25;12(1):e003548. doi: 10.1136/bmjdrc-2023-003548.},
  language = {eng},
}